Accendra Health (NYSE:ACH) Given New $6.00 Price Target at Robert W. Baird

Accendra Health (NYSE:ACH) had its price target increased by equities researchers at Robert W. Baird from $5.00 to $6.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s price target would indicate a potential upside of 52.67% from the stock’s current price.

A number of other equities analysts also recently commented on the stock. Weiss Ratings assumed coverage on shares of Accendra Health in a research note on Wednesday, April 8th. They set a “sell (e+)” rating for the company. Zacks Research upgraded shares of Accendra Health from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 21st. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $6.00.

Accendra Health Stock Performance

ACH stock opened at $3.93 on Tuesday. The firm has a market capitalization of $300.41 million, a PE ratio of -0.28, a P/E/G ratio of 2.91 and a beta of 1.70. Accendra Health has a twelve month low of $1.84 and a twelve month high of $9.55.

Accendra Health (NYSE:ACH) last released its quarterly earnings data on Monday, May 11th. The company reported ($0.04) EPS for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.02. Accendra Health had a negative net margin of 23.32% and a negative return on equity of 50.04%. The business had revenue of $627.78 million during the quarter. On average, analysts expect that Accendra Health will post 0.6 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Accendra Health

Hedge funds have recently modified their holdings of the business. Keybank National Association OH acquired a new position in Accendra Health in the first quarter valued at $46,000. Strs Ohio bought a new stake in shares of Accendra Health during the first quarter worth about $413,000. Abel Hall LLC bought a new stake in shares of Accendra Health during the first quarter worth about $44,000. Hsbc Holdings PLC bought a new stake in shares of Accendra Health during the first quarter worth about $34,000. Finally, Bank of New York Mellon Corp bought a new stake in shares of Accendra Health during the first quarter worth about $592,000.

About Accendra Health

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.